Effects of diphenylaminoethanol (DPAE) on GABA and synaptic inhibitions in the cerebral and cerebellar cortices.
D000470:Alkaloids / Q000494:pharmacology; D000605:Amino Alcohols / Q000008:administration & dosage; D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001555:Benzene Derivatives / Q000494:pharmacology; D002415:Cats; D002525:Cerebellar Cortex / Q000187:drug effects*; D002540:Cerebral Cortex / Q000187:drug effects*; D004149:Dioxoles / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D007275:Injections, Intravenous; D007478:Iontophoresis; D007546:Isoquinolines / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects; D011689:Purkinje Cells / Q000187:drug effects; D051381:Rats; D013569:Synapses / Q000187:drug effects*; D013997:Time Factors; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000494:pharmacology*
D000470:Alkaloids; D000605:Amino Alcohols; D000613:Aminobutyrates; D001555:Benzene Derivatives; D004149:Dioxoles; D004983:Ethanolamines; D007546:Isoquinolines; D005680:gamma-Aminobutyric Acid; C007514:diphenylaminoethanol